News
EuroAPI Announces New Governance
Chair of the Board Viviane Monges Appointed Interim Chief Executive Officer
The Board of Directors also appointed Elizabeth Bastoni, Chair of the Nominations and Compensation Committee, as the Independent Lead-Director to oversee the company's governance and engage with shareholders on Board-related matters.
The Board of Directors thanked Karl Rotthier for his contributions to EuroAPI since 2021, notably during EuroAPI’s early days, establishing the Company as a new independent major active pharmaceutical ingredient (API) and contract development and manufacturing organization (CDMO) actor on the market. The Board will continue to support the Group’s transformation in a fast-evolving environment and will actively oversee the execution of the strategic review announced earlier this month.
-
Viviane Monges, Chair of EuroAPI’s Board of Directors appointed Chief Executive Officer for an interim period, effective October 30, 2023. © EuroAPI
-
Karl Rotthier to step down as Chief Executive Officer, effective October 30, 2023. © EuroAPI
